NYSE:LGPSStock Market
LogProstyle Shares Slip 30% Premarket After 75% Surge on I-FLATZ Acquisition
LogProstyle Inc. fell 30.3% ahead of Friday’s session, erasing gains from a 74.9% surge the day before on takeover news. The swift decline signals…
Market intelligence
Latest market intelligence
Fast, evidence-led coverage of the companies and events moving global markets.
All coverage
More market stories
NYSE American: LGPS · I-FLATZ acquisition
The rally repriced an undisclosed deal
Thursday added about $15.3 million of equity value. Friday’s premarket reversal retained roughly $4.5 million, while purchase price and target financials remain absent.
Market snapshot
Aug. 28, 2026 · 05:36 EDT
Compiled 11:38 CEST
Aug. 28, 2026 · 05:36 EDT
Compiled 11:38 CEST
Thursday close
$1.52
+74.9%
Acquisition rally
Friday premarket
$1.06
−30.3%
401,358 shares
Two-session net
+21.8%
vs. $0.87 base
Still above Wednesday
Market capitalization
$35.9M
23.61M shares
Micro-cap, thin float
Market-value bridge
Illustrative equity-value changes use 23.61 million shares outstanding. Premarket quotes can change quickly.
Disclosure gap
Known 100% of I-FLATZ; 3,800 target shares.
Known Closing targeted for September.
Not disclosed: purchase price, revenue, EBITDA, assets, debt or expected accretion.
LogProstyle FY2026
| Metric | Reading | Signal |
|---|---|---|
| Revenue | ¥22.22B | +7.6% |
| Real-estate revenue | ¥20.60B | +9.5% |
| Operating income | ¥1.57B | +17.1% |
| Operating margin | 7.1% | 6.5% prior year |
| Adjusted EBITDA | ¥1.64B | +10.6% |
| Net income | ¥760M | +0.8% |
Balance sheet and concentration
| Indicator | Reading | Investor read |
|---|---|---|
| Cash | ¥2.28B | Funding buffer |
| Short-term borrowings | ¥1.61B | Refinancing exposure |
| Long-term borrowings | ¥15.54B | Material leverage |
| LogSuite Tokyo revenue | 100% | Kansai diversifies |
| Float | 6.36M shares | Volatility amplifier |
Deal timeline
August 27Agreement signed for 100% of I-FLATZ.
August 27 closeLGPS ends at $1.52 after a 74.9% rally.
August 28 premarketShares retreat to $1.06 on 401,358 shares.
September targetClosing expected if conditions are satisfied.
What investors need next
1 Purchase price and financing structure.
2 I-FLATZ revenue, margin, inventory and debt.
3 Integration costs and synergy timetable.
4 Regular-session price discovery after extreme volume.
No reliable current Wall Street consensus coverage was available.
Sources
Acquisition announcement · Company financial materials · Premarket movers · SEC filings
Risk flag
Valuation moved before economics arrived.
The deal may not close. Undisclosed consideration, leverage, thin float and integration risk can drive further reversals.
Market figures timestamped Aug. 28, 2026, 05:36 EDT. Financial figures are for the fiscal year ended March 31, 2026.
NASDAQ:VISNShare Buybacks
Vistance Stock Sinks 42.7% Premarket After $5 Payout, Boosts Buyback by $150 Million
Vistance Networks Inc. shares looked set to fall 42.7% ahead of Friday’s open, largely due to a planned $5 special cash payout, rather than…
NASDAQ: VISN · Vistance Networks
The 42.7% “drop” is mostly a $5 cash adjustment
The clean comparison is Friday’s $6.67 premarket quote plus the $5.00 distribution. That produces $11.67, nearly flat against Thursday’s $11.63 reference close.
Premarket snapshot
Aug. 28, 2026 · 05:27 EDT
Compiled 11:29 CEST
Aug. 28, 2026 · 05:27 EDT
Compiled 11:29 CEST
Premarket quote
$6.67
−42.65% unadjusted
7,420 shares traded
Special distribution
$5.00
Paid Aug. 27
Ex-date Aug. 28
Adjusted value
$11.67
about +0.3%
$6.67 quote + $5 cash
New authorization
$150M
Added to buyback
Timing remains discretionary
Price bridge: unadjusted feed versus economic comparison
Before taxes and trading costs. Low premarket volume limits price discovery.
Capital-return math
Illustrative shares at $6.67
22.5M
As % of Q2 diluted shares
9.6%
$150 million divided by $6.67. This is a scenario, not a forecast; the program does not require purchases.
Operating scorecard · Q2 2026
| Metric | Reading | Change / signal |
|---|---|---|
| Net sales | $319.6M | −1.4% YoY |
| Adjusted EBITDA | $35.8M | −32.1% YoY |
| Core Aurora margin | 14.2% | 24.7% prior year |
| Free cash flow | −$74.7M | Cash use |
| FY EBITDA guidepost | $200M–$225M | Cut by $25M |
Balance sheet and valuation watch
| Signal | Reading | Investor test |
|---|---|---|
| Expected year-end cash | $700M–$750M | No outstanding debt expected |
| Expected 2027 tax refund | $160M | Additional optionality |
| Analyst consensus | Hold · 4 ratings | Targets may need adjustment |
| Average target | $14.67 | Verify post-distribution basis |
| Premarket volume | 7,420 | Thin price discovery |
Corporate-action timeline
July 1Ruckus sale closed for about $1.846 billion cash.
August 6Board declared the $5 special distribution.
August 26Board added $150 million to repurchase authority.
August 27Distribution paid to eligible holders.
August 28Shares trade ex-distribution; options adjust.
What matters next
1 Regular-session liquidity should reveal the cleaner post-payment valuation.
2 Repurchase disclosures will show whether authorization becomes actual demand.
3 Aurora’s 14.2% core margin must stabilize against memory costs and stranded expenses.
4 Cash deployment must balance buybacks, organic investment and acquisitions.
Primary references
$5 special distribution · $150 million buyback increase · Q2 2026 results · OCC contract adjustment
Risk flag
Do not read the raw −42.65% as like-for-like.
The buyback is discretionary. Aurora still faces margin pressure, negative recent free cash flow and post-divestiture execution risk.
BankruptcyPharmaceuticals
BioXcel Shares Sink 62% as Chapter 11 Filing Leaves Equity Subordinate to $100M–$500M Debt
BioXcel Therapeutics Inc. dropped nearly 62% ahead of Friday's session following the company's decision to seek Chapter 11 bankruptcy protection. The move changes a…
BioXcel Therapeutics · NASDAQ: BTAI
Chapter 11 turns a pipeline valuation into a recovery waterfall.
Premarket: Aug. 28, 2026, 05:10 EDT
Compiled: Aug. 28, 2026, 05:14 EDT
Compiled: Aug. 28, 2026, 05:14 EDT
Premarket price$0.27−62.4%
Premarket volume~975KBefore the open
Estimated assets$10M–$50MChapter 11 petition
Estimated liabilities$100M–$500M2×–50× asset range
Claims scale versus disclosed assets
Assets: low
$10M
Assets: high
$50M
Liabilities: low
$100M
Liabilities: high
$500M
Equity bridge
Even the lowest liability estimate is twice the highest disclosed asset estimate. Common shares receive value only after secured, priority and unsecured claims are satisfied.
Even the lowest liability estimate is twice the highest disclosed asset estimate. Common shares receive value only after secured, priority and unsecured claims are satisfied.
Recovery waterfall
1Secured lenders
Collateral and court-approved financing come first.
Collateral and court-approved financing come first.
2Priority claims
Administrative costs and eligible employee or tax claims.
Administrative costs and eligible employee or tax claims.
3Unsecured creditors
Recovery depends on asset-sale and plan value.
Recovery depends on asset-sale and plan value.
4Common equity
Residual claim; cancellation or major dilution is possible.
Residual claim; cancellation or major dilution is possible.
Operating and liquidity snapshot
Commercial revenue remained small relative to losses. Before court protection, available cash represented roughly 1.5 quarters of the cited operating burn.
Next decision points
Voluntary Chapter 11 petition filed in Delaware.
Court considers cash management, employee payments and any debtor-in-possession financing.
Potential sale process, restructuring-support agreement or standalone plan.
Nasdaq and broker notices may change listing status, liquidity or trading access.
Sale proceeds and allowed claims determine whether equity receives anything.
Bear case
Shares are canceled after proceeds fail to cover creditor claims.
Shares are canceled after proceeds fail to cover creditor claims.
Base case
Assets are sold and recoveries accrue mainly to creditors.
Assets are sold and recoveries accrue mainly to creditors.
Upside case
A competitive bid materially exceeds disclosed asset expectations; equity still remains subordinate.
A competitive bid materially exceeds disclosed asset expectations; equity still remains subordinate.
EarningsNASDAQ:DLTR
Dollar Tree Slides 3.9% After Q3 EPS Forecast of $0.80–$0.95 Disappoints
CHESAPEAKE, August 28, 2026, 05:04 - Shares in Dollar Tree declined 3.9% following the retailer's projection for third-quarter earnings per share of $0.80 to…
Dollar Tree (NASDAQ: DLTR)
Strong quarter, deliberate Q3 margin reset
Market data: Aug. 27, 2026, 16:00 EDT
Dashboard compiled: Aug. 28, 2026, 05:07 EDT
Dashboard compiled: Aug. 28, 2026, 05:07 EDT
Closing price$127.00−3.92%
Trading volume5.56MAug. 27 close
Q2 revenue$4.89B+7.0% YoY
Q3 adjusted EPS guide$0.80–$0.95vs. $1.40 consensus
Operating momentum
*Midpoint of $0.875 versus $1.40 consensus.
Guidance map
Q3 sales$5.0B–$5.1BComps +3%–4%
FY2026 sales$20.5B–$20.7BMaintained
FY2026 adj. EPS$7.70–$8.05Raised
Investor bridge
$383 million of tariff refunds boosted Q2 results. Management expects about $0.50 per share of Q3 reinvestment pressure, trading immediate margin for pricing, marketing and store execution.
$383 million of tariff refunds boosted Q2 results. Management expects about $0.50 per share of Q3 reinvestment pressure, trading immediate margin for pricing, marketing and store execution.
Margin and cash signals
Operating cash$922MContinuing operations
Free cash flow$675MQ2 fiscal 2026
Q2 buybacks$605M$2.5B authorization left
Valuation and expectations
DLTR closed at $127.00, nearly matching the $127.90 average analyst target.
20-analyst survey: Hold. Expectations leave little room for a delayed payoff from reinvestment.
Dollar General rallied while Dollar Tree fell, showing that investors rewarded near-term earnings visibility.
Q3 traffic and gross margin will show whether lower prices convert refund cash into durable share gains.
DownsideRefund rules change, price investment persists, or fuel and wage costs erode gross-margin gains.
Base caseComps stay near 3%–4%, while earnings trough in Q3 and recover into the holiday quarter.
UpsideTraffic accelerates, shrink improves and multi-price stores lift ticket without heavier promotions.
EarningsNYSE:DG
Dollar General Shares Gain 2.5% on Improved Traffic Driving EPS to $2.48
Shares of Dollar General Corporation gained 2.5% on Thursday, supported by higher customer traffic, improved margins and an upgraded forecast. The stock ended the…
NYSE: DG
Dollar General investor dashboard
Traffic growth, margin recovery and resumed buybacks support the turnaround.
Close: Aug. 27, 2026, 4:00 p.m. EDT
Compiled: Aug. 28, 2026, 4:52 a.m. EDT
Compiled: Aug. 28, 2026, 4:52 a.m. EDT
Close
$125.89
+2.53%
Day range: $124.50–$132.50
Q2 net sales
$11.29B
+5.2% YoY
Beat consensus near $11.2B
Same-store sales
+3.5%
Traffic +2.0%
Average ticket +1.5%
Diluted EPS
$2.48
+33.3% YoY
Consensus near $2.00
Quarterly operating scorecard
Gross margin expanded 127 basis points to 32.6%; tariff refunds contributed about 81 basis points.
Stock reaction
- Shares rose as much as 8% early.
- The close retained a 2.5% gain.
- Volume reached roughly 6.4M shares.
- The fade shows concern about temporary tariff benefits.
- Market value ended near $27.8B.
Guidance reset
| Metric | New FY26 view | Previous |
|---|---|---|
| Net-sales growth | 4.0%–4.3% | Lower range |
| Same-store sales | 2.5%–2.9% | 2.2%–2.7% |
| Diluted EPS | $7.80–$8.00 | $7.20–$7.45 |
| Second-half buybacks | Up to $700M | Paused |
Consumer signal
| Indicator | Reading | Interpretation |
|---|---|---|
| Customer traffic | +2.0% | Fifth positive quarter |
| Average transaction | +1.5% | Modest basket growth |
| $1 category sales | +16% | Value demand outpaced chain comps |
| Planned $1 assortment | +40% | Holiday 2026 expansion |
Valuation and capital return
$700M of planned buybacks equals about 2.5% of market capitalization. Consensus target upside is roughly 7%.
Risk monitor
- Fuel and food inflation
- Non-recurring tariff refunds
- Wage, freight and shrink costs
- Low-income consumer pressure
- Giveback of early stock gains
Investor takeaway
Dollar General’s core indicators improved together: traffic, ticket, gross margin and operating profit. The raised outlook and resumed buybacks strengthen the case. The smaller closing gain shows investors are discounting the portion of earnings tied to tariff refunds.
Sources: Dollar General fiscal Q2 2026 results; Reuters; Google Finance and Robinhood closing data; analyst estimates as of Aug. 27, 2026.
EarningsNASDAQ:OKTA
Okta Shares Jump 28.6% as cRPO Growth Reaches 14%
Shares of Okta Inc. jumped 28.6% on Thursday following reports of faster backlog growth and an upgraded annual forecast. The stock ended the session…
NASDAQ: OKTA
Okta investor dashboard
Backlog acceleration and cash conversion drive a sharp re-rating.
Close: Aug. 27, 2026, 4:00 p.m. EDT
Compiled: Aug. 28, 2026, 4:44 a.m. EDT
Compiled: Aug. 28, 2026, 4:44 a.m. EDT
Close
$172.91
+28.63%
Intraday high: $174.85
Volume
16.36M
3.6× average
Average: 4.52M
Market cap
$30.05B
166.12M shares outstanding
Free-cash-flow margin
28%
+6 pts YoY
$227M in Q2 FY2027
Operating momentum
Q2 FY2026Q2 FY2027
Why investors reacted
- cRPO growth accelerated to 14%.
- RPO reached $4.858 billion.
- Free cash flow rose 40% to $227 million.
- FY27 cash-flow guidance increased.
- New identity products added to core growth.
Quarter comparison
| Metric | Q2 FY27 | YoY |
|---|---|---|
| Revenue | $805M | +11% |
| Subscription revenue | $793M | +12% |
| RPO | $4.858B | +17% |
| cRPO | $2.585B | +14% |
| GAAP operating income | $107M | +161% |
| Free cash flow | $227M | +40% |
Forward guide
| Period | Metric | Guidance |
|---|---|---|
| Q3 FY27 | Revenue | $813M–$817M |
| Q3 FY27 | cRPO | $2.590B–$2.600B |
| Q3 FY27 | Operating margin | 24%–25% |
| FY27 | Revenue | $3.216B–$3.226B |
| FY27 | Free cash flow | $910M–$930M |
| FY27 | FCF margin | 28%–29% |
Analyst targets after earnings
The close already exceeds some targets, leaving execution rather than estimate revision as the next support.
Risk monitor
- cRPO volatility from large contracts
- Growth slower than historic rates
- AI identity competition
- Premium valuation after the rally
- Guidance execution over two quarters
Investor takeaway
Okta’s rally rests on a measurable combination: faster near-term backlog growth, a doubled GAAP operating margin and 28% free-cash-flow conversion. The stock now prices in continued cRPO expansion and little tolerance for a guidance miss.
Sources: Okta fiscal Q2 2027 release; Nasdaq closing data; analyst actions dated Aug. 27, 2026. Non-GAAP guidance is management’s estimate.
PharmaceuticalsStock Market
Biohaven Stock Falls 4.9% as Raymond James Cuts Target to $30 After Opakalim Deal
Biohaven Ltd. shares fell 4.9% on Thursday after Raymond James cut its price target by 40%. The stock closed at $16.12.
NYSE: BHVN
Biohaven investor dashboard
Opakalim monetization improves liquidity and shifts value toward BHV-1300.
Market data: Aug. 27, 2026, 4:00 p.m. EDT
Compiled: Aug. 28, 2026, 4:39 a.m. EDT
Compiled: Aug. 28, 2026, 4:39 a.m. EDT
Close
$16.12
−4.90%
Day range $15.50–$17.05
Volume
5.43M
175% of average
65-day average: 3.11M
Market cap
$2.43B
151.04M shares outstanding
Raymond James target
$30
+86% vs. close
Cut from $50; Strong Buy retained
Liquidity reset: cash received versus June balance
The $400 million cash component equals about 1.7 times Biohaven’s June 30 cash and equivalents. Total upfront and milestone payments may reach $795 million; milestones remain contingent.
What moved the stock
- Raymond James removed opakalim’s full economics from its model.
- The price target fell 40%, to $30 from $50.
- The deal removes near-term clinical risk and extends runway through 2028.
- Valuation now depends more heavily on BHV-1300 execution.
Analyst reference points
| Firm | Rating | Target | Upside |
|---|---|---|---|
| Raymond James | Strong Buy | $30 | 86% |
| RBC Capital | Outperform | $23 | 43% |
Targets are not forecasts. Raymond James updated Aug. 26; RBC followed second-quarter results.
Pipeline value map
| Asset | Status | Investor signal |
|---|---|---|
| Opakalim / BHV-7000 | Licensed to SK Biopharmaceuticals | Cash now; royalties and milestones later |
| BHV-1300 | Pivotal Graves’ disease study | Late-2027 data is the central readout |
| Remaining pipeline | Clinical-stage | Must justify the $2.43B equity value |
Stock context
CloseRBC targetRaymond James target
Risk monitor
- Clinical efficacy or safety failure
- Trial or regulatory delay
- Higher-than-planned cash burn
- Contingent milestones not earned
- 13.87% of float sold short
Investor takeaway
Biohaven exchanged part of opakalim’s long-term upside for immediate balance-sheet strength. The 4.9% decline and above-average volume show investors are recalibrating that trade. The next valuation test is whether BHV-1300 can turn a longer runway into credible pivotal data.
Sources: Biohaven Q2 2026 update and pipeline materials; MarketWatch closing data; Raymond James and RBC analyst actions reported Aug. 2026. Figures may be delayed.
EnergyNYSE:BAK
Braskem Shares Rise 10.8% After Petrobras Increases Credit Facility to R$2.35 Billion
Braskem S.A. ADRs surged 10.8% to hit $1.64 on Thursday. Trading volume soared to 8.04 million shares, significantly higher than the 2.51 million share…
Braskem liquidity dashboard
A large supplier-credit headline against a much larger debt problem.
Market close: Aug. 27, 2026, 16:00 EDT
Compiled: Aug. 28, 2026, 04:30 EDT
Compiled: Aug. 28, 2026, 04:30 EDT
BAK close
$1.64
+10.81%
Volume
8.04M
3.2× average
Credit ceiling
R$2.35B
From R$350M
Unsecured restructuring
US$10.9B
90-day process
Scale mismatch
The Petrobras line supports feedstock purchases; it is not a balance-sheet recapitalization.
Credit-control waterfall
Valuation and stress signals
| Signal | Reading | Investor interpretation |
|---|---|---|
| Market capitalization | ~$283M | Thin equity cushion |
| Enterprise value | ~$12.24B | Debt dominates valuation |
| Trailing net income | −$978M | Equity cannot absorb prolonged losses |
| Operating margin | 0.76% | Little room for feedstock or spread shocks |
| 52-week position | $1.64 vs $1.40–$5.39 | Relief rally near the low |
| Analyst posture | JPM Neutral; Citi Sell; BofA Underperform | Caution predates the new facility |
What changed
Petrobras lifted the supplier-credit ceiling by R$2.0 billion and kept 30-day payment terms through December. That improves feedstock continuity during restructuring.
What still must happen
The rally becomes durable only if operating continuity converts into a viable creditor agreement.
![UK Stock Market Today 28/08/2026 [UPDATE: 16:47 BST] [SSE Leads FTSE Close as Warsh Lifts Gilt Yields]](https://ts2.tech/wp-content/uploads/2026/08/UK-market-dashboard-2026-08-28-1647-1024x683.jpg "UK Stock Market Today 28/08/2026 [UPDATE: 16:47 BST] [SSE Leads FTSE Close as Warsh Lifts Gilt Yields]")
Stock Market
UK Stock Market Today 28/08/2026 [UPDATE: 16:47 BST] [SSE Leads FTSE Close as Warsh Lifts Gilt Yields]
SSE Leads FTSE Close as Warsh Lifts Gilt Yields28/08/2026 · 16:47 BST UK EQUITIES · CLOSING READ SSE leads a positive close as gilt…
NASDAQ:DKNGNYSE:FLUT
DraftKings Shares Drop 2.3% with NFL Reviving Competition with FanDuel Before $30 Billion Season
The NFL has extended its multi-year sportsbook agreements with DraftKings Inc. and Flutter Entertainment plc's FanDuel, and introduced Fanatics, a privately owned company, as…
draftkings vs fanduel
NFL distribution is secured; unit economics remain the real contest.
Market data: Aug. 27, 2026 close / Aug. 28, 04:01 EDT
Compiled: Aug. 28, 2026, 04:20 EDT
Compiled: Aug. 28, 2026, 04:20 EDT
DKNG close
$24.22
−2.26%
DKNG premarket
$24.44
+0.91%
NFL legal wagers
$30B
2025 season estimate
2026 kickoff
Sep. 9
First monetization test
DraftKings Q2 operating scorecard
Volume and users expanded, but game outcomes and promotions compressed monetization.
Stock context
The renewal preserved distribution but did not reverse the de-rating.
Operator comparison
| Signal | DraftKings | FanDuel parent Flutter | What matters |
|---|---|---|---|
| Q2 revenue | $1.443B, −5% | $4.326B, +3% groupwide | Growth quality diverged |
| Activity | $13.1B sports volume, +15% | FanDuel retains NFL sportsbook status | Access is broad; conversion decides value |
| Profit signal | FY26 EBITDA guide $700M–$900M | Q2 adjusted EBITDA $508M, −45% | Promotions and taxes pressure margins |
| Market close | $24.22, −2.3% | $95.01, −3.1% | Investors remain cautious |
Why the NFL renewal matters
DraftKings and FanDuel retain promotion, real-time statistics, event presence and NFL digital integrations. DraftKings also keeps daily fantasy status. Fanatics joins as a third sportsbook partner and gains online-casino marketing rights.
Investor checklist
Positive: payer retention and cross-sell. Negative: customer-friendly results or higher acquisition costs.
Artificial IntelligenceCloud Computing
Salesforce Shares Jump 22.6% with AI and Data ARR Approaching $3.9 Billion
Salesforce Inc. rose 22.6% on Thursday, as improved contract growth and increased cash flow boosted investor faith in its AI approach.
Salesforce Q2 FY2027 investor dashboard
AI monetization accelerates; valuation catches up quickly.
Market close: Aug. 27, 2026, 16:00 EDT
Compiled: Aug. 28, 2026, 04:10 EDT
Compiled: Aug. 28, 2026, 04:10 EDT
CRM close$252.05+22.58%
Volume55.52M4.4× recent average
Market value$206.4B≈+$38B in one day
Analyst target$2675.9% above close
Quarterly operating scorecard
| Metric | Value | Growth |
|---|---|---|
| Revenue | $11.35B | +11% |
| cRPO | $33.5B | +14% |
| Agentforce + Data 360 ARR | ≈$3.9B | >+210% |
| Free cash flow | $1.1B | +81% |
| GAAP operating margin | 20.5% | — |
Guidance raise composition
Updated FY2027 revenue range: $46.1B–$46.4B. Contentful and Fin remain pending.
FY2027 revenue$46.1B–$46.4B+11%–12%
FY2027 non-GAAP margin34.3%maintained
Q3 revenue$11.42B–$11.50B+11%–12%
Q3 cRPO growth≈14%excludes pending deals
Analyst positioning
| Rating | Count | Share |
|---|---|---|
| Buy | 29 | |
| Hold | 9 | |
| Sell | 1 |
39 analysts; targets range from $160 to $400. Data viewed Aug. 28, 2026.
Investor checklist
Organic revenueAI usage pricingcRPOContentful closeFin closeCash conversion
| Signal | Bull case | Risk case |
|---|---|---|
| AI monetization | ARR sustains triple-digit growth | Usage fails to lift core growth |
| Guidance quality | Organic raise expands | Acquisitions carry the increase |
| Valuation | Targets move higher | Close already nears consensus |
| Margins | Cash growth stays ahead of sales | Integration costs pressure leverage |
Sources: Salesforce Q2 FY2027 release; Public/Xignite closing data; Google Finance analyst data; Reuters. Prices as of Aug. 27 close. Not investment advice.
BiotechnologyFinancial Forecasts
Celularity shares jump 138.5% after forecasting $300 million MuseCell manufacturing revenue
Celularity Inc. stock surged over 100% on Thursday, following news of a manufacturing deal that shifted the conversation over the financially challenged cell-therapy firm's…
Celularity / MuseCell investor dashboard
Potential contract scale meets extreme liquidity and execution risk.
Market close: Aug. 27, 2026, 16:00 EDT
Compiled: Aug. 28, 2026, 03:10 EDT
Compiled: Aug. 28, 2026, 03:10 EDT
CELU close$2.10+138.5%
Volume221.1Mshares
Market value$60.8Mclosing estimate
Potential purchases>$300Mfive-year MCI estimate
Scale comparison
| Measure | USD | Relative scale |
|---|---|---|
| Five-year purchase estimate | >$300M | |
| Closing market value | $60.8M | |
| 2025 revenue | $26.6M | |
| Year-end cash | $6.2M |
The $300M figure is a partner projection, not committed revenue.
Fundamental pressure
Revenue fell 51%; the net loss widened 58%.
Facility147,215 sq. ft.
Florham Park, New Jersey
Cleanroom suites15
9 Grade C + 6 Grade D
Potential jobs>200
projected, not guaranteed
FDA statusNot approved
Named products remain unlicensed.
What investors should watch next
Technology transferProcess qualificationBinding ordersCash receiptsFinancing termsSEC filing compliance
| Signal | Bull case | Risk case |
|---|---|---|
| Commercial conversion | Signed minimum purchases | Forecast remains nonbinding |
| Liquidity | Upfront payments fund scale-up | Equity issuance dilutes holders |
| Manufacturing | Validated lots and release criteria | Qualification delays or batch variability |
| Regulatory | Clear development pathway | No FDA approval for named products |
Sources: Celularity/MuseCell Business Wire release, Aug. 27, 2026; Celularity 2025 Form 10-K; Public/Xignite closing market data. Figures are historical or issuer projections, not investment advice.
Artificial IntelligenceNASDAQ:INTC
Intel Stock Rises 4.4% as Nvidia Forecast Revives AI-Chip Demand
Intel Corporation rose 4.36% on Thursday as Nvidia's forecast revived confidence in AI infrastructure spending.
NASDAQ: INTC · AI-demand spillover
Intel gains, but dilution still sets the hurdle
Nvidia's forecast lifted Intel 4.36%; the close remains below Intel's recent $95 share-sale price.
Market data: Aug. 27, 2026, 20:15 EDT
Financials: Q2 2026
Financials: Q2 2026
Close
$92.09
High $92.92 · Low $88.51
Daily move
+4.36%
+$3.85 per share
Volume
100.56M
+32.7% vs. Aug. 26
Market value
$470.0B
About +$19.6B on the day
Five-session Intel close
Why the stock moved
Nvidia move+8.72%AI-spending confidence
Nvidia forecast~70%next-fiscal-year revenue growth
Offering price$95.00Intel close is 3.1% lower
ConsensusHold$114.88 average target
Peer reaction and valuation
| Company | Close | Move | Volume | Trailing P/E |
|---|---|---|---|---|
| Intel | $92.09 | +4.36% | 100.56M | N/M |
| Nvidia | $227.98 | +8.72% | 298.91M | 28.6× |
| AMD | $476.67 | −0.86% | 16.44M | 122.5× |
| Micron | $935.39 | −0.36% | 28.84M | 21.2× |
The split tape matters: Thursday rewarded Intel's AI exposure, but the whole semiconductor group did not rally.
Intel operating scorecard
| Q2 revenue | $16.1B | +25% |
| GAAP gross margin | 40.4% | +12.9 pts |
| GAAP operating margin | 11.1% | +35.8 pts |
| Non-GAAP net income | $2.2B | vs. loss |
| GAAP net result | −$11.0B | loss |
What investors are pricing
Operations improve
Revenue and margins rose sharply, but the GAAP loss kept earnings quality in focus.
$20B equity raise
Intel sold 210.5 million shares at $95, creating a clear dilution and execution benchmark.
AI demand rerates Intel
Nvidia's forecast lifted Intel, yet no new Intel design win was announced.
Investor takeaway
Intel's 4.36% gain says the market sees value in its exposure to expanding AI budgets. The harder test is conversion: foundry utilization, server share, margin durability and cash generation must justify both a $470 billion valuation and the new capital raised at $95.
![US Stock Market Today 08/28/2026 [UPDATE: 20:07 EDT] [Nvidia Holds Slight Gain as Marvell Ends After Hours Lower]](https://ts2.tech/wp-content/uploads/2026/08/US-market-dashboard-2026-08-28-2000-1024x683.jpg "US Stock Market Today 08/28/2026 [UPDATE: 20:07 EDT] [Nvidia Holds Slight Gain as Marvell Ends After Hours Lower]")
Stock Market
US Stock Market Today 08/28/2026 [UPDATE: 20:07 EDT] [Nvidia Holds Slight Gain as Marvell Ends After Hours Lower]
Nvidia Holds Slight Gain as Marvell Ends After Hours Lower08/28/2026 · 20:07 EDT NASDAQ AFTER-HOURS · ACTIVE AT RUN START Nvidia holds a slight…
CybersecurityEarnings
CrowdStrike Shares Surge 20.5% as Annual Recurring Revenue Hits $5.84 Billion
CrowdStrike Holdings jumped 20.5% to $227.96 on Thursday after the company reported record recurring-revenue growth and raised its annual outlook. Trading volume reached roughly…
NASDAQ: CRWD · Q2 FY2027 earnings reaction
CrowdStrike: acceleration earns a 20.5% rerating
Record net new ARR and stronger cash conversion pushed the stock near fresh highs. The valuation now leaves less room for a routine quarter.
Market close: Aug. 27, 2026, 16:00 EDT · Financials: quarter ended July 31, 2026Close
$227.96
+$38.78 · +20.5%
Volume
23.45M
earnings-driven activity
Ending ARR
$5.84B
+25% year over year
Net new ARR
$333M
+51% year over year
Price reaction
The pre-report reference is inferred from the 20.5% one-day move. Closing data are timestamped Aug. 27, 2026, 16:00 EDT.
What changed
Net new ARR accelerated faster than total ARR. Falcon Flex ARR exceeded $2.29B and grew 101%, showing larger platform commitments rather than a narrow seat expansion.
| Revenue guide midpoint | $6.001B |
| Prior midpoint | $5.935B |
| Guide increase | $66M |
| Q3 revenue midpoint | $1.526B |
Fundamentals
| Metric | Q2 FY27 | Change |
|---|---|---|
| Revenue | $1.471B | +26% |
| Subscription revenue | $1.400B | +27% |
| GAAP subscription margin | 78% | +1 pt |
| Operating cash flow | $530.3M | +59% |
| Free cash flow | $377.4M | +33% |
| GAAP operating loss | ($33.2M) | improved $72.3M |
Module depth
6+ modules · 51%
7+ modules · 35%
8+ modules · 26%
Adoption rates among subscription customers as of July 31, 2026.
Peer tape · Aug. 27 close
| Company | Ticker | Daily move |
|---|---|---|
| Okta | OKTA | +28.6% |
| CrowdStrike | CRWD | +20.5% |
| Palo Alto Networks | PANW | +12.8% |
| ServiceNow | NOW | +10.0% |
Software and security stocks also benefited from renewed AI spending confidence.
Valuation and expectations
| Implied equity value | ~$238B |
| FY27 guide midpoint multiple | ~39.7× sales |
| Raised analyst targets | $238–$250 |
| Upside to target range | 4.4%–9.7% |
| Consensus | Buy · 44 analysts |
Equity value uses $227.96 and 1.044B diluted weighted-average shares. It is an approximation, not the exchange-reported market capitalization.
Catalyst timeline
Risk monitor
Valuation risk is immediate: raised price targets sit close to the market price.
Other watchpoints: long enterprise sales cycles, intense platform competition, acquisition integration, and $399.0M of quarterly stock-based compensation.
NYSE:DISStock Market
Toy Story 5 Arrives on Disney+ September 23 Following $1.13 Billion Box Office Success
Toy Story 5 is set to debut on Disney+ on September 23, following a global theatrical performance that brought in $1.129 billion. This release…
Toy Story 5 · Disney+ investor dashboard
A $1.13 billion theatrical hit enters Disney’s recurring-revenue funnel
The September 23 streaming debut extends a proven franchise into an SVOD business growing revenue by double digits.
Worldwide box office$1.129BThrough Aug. 27, 2026
Reported production budget$250MGross equals 4.5× budget
Disney SVOD revenue growth+11%Fiscal Q3 YoY
SVOD operating margin13%Fiscal Q3 2026
Next catalyst
SEP 23
Disney+ streaming launch
Window sequence: theaters → digital storefronts → subscription streaming.
Box-office demand already proved
Domestic receipts supplied 42.4% of worldwide gross. The opening accounted for 33.4% of the final domestic total, showing sustained demand beyond launch weekend.
Stock snapshot
| Metric | Value |
|---|---|
| Price | $106.82 |
| Session move | −2.60% |
| Market capitalization | $186.2B |
| Trailing P/E | 22.1× |
| Volume | 8.70M shares |
Quote timestamp: Aug. 27, 2026, 19:29 EDT. The available data do not attribute the decline to the streaming announcement.
How the franchise reaches Disney’s accounts
1 · Theatrical$1.129B worldwide gross; immediate studio economics after exhibitor splits and marketing.
2 · Consumer productsToy Story 5 and Star Wars helped Consumer Products revenue grow 7% in fiscal Q3.
3 · Disney+More than two billion Toy Story hours were already streamed before the new film’s debut.
Disney financial signals
| Fiscal Q3 metric | Result | YoY |
|---|---|---|
| Total revenue | $25.25B | +7% |
| Entertainment revenue | $11.35B | +6% |
| Entertainment operating income | $1.68B | +64% |
| SVOD subscription revenue | — | +15% |
| SVOD advertising revenue | — | +3% |
| Free cash flow | $3.07B | +63% |
Quarter ended June 27, 2026; results reported August 5. Disney reiterated roughly 16% adjusted EPS growth for fiscal 2026 including the 53rd week.
What investors should watch
Engagement: whether a theatrical winner raises viewing and lowers Disney+ churn.
Margin: incremental use of an owned film library should support the 13% SVOD margin if marketing stays disciplined.
Window trade-off: subscription availability follows digital sales by 36 days and may curb later purchase revenue.
Disclosure gap: Disney has not published a title-level subscriber or retention target. Current Street consensus is omitted because no live figure was independently verified.
Sources: Disney fiscal Q3 shareholder letter · The Numbers · release announcement coverage · Google Finance. Market figures timestamped Aug. 27, 2026, 19:29 EDT.